CSIMarket
 


Fresenius Medical Care Ag  (FMS)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

FMS's Net Income Growth by Quarter and Year

Fresenius Medical Care Ag's Net Income results by quarter and year




FMS Net Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 820.35 1,001.64 1,365.31 1,608.13
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 0.00 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   820.35 1,001.64 1,365.31 1,608.13



FMS Net Income fourth quarter 2023 Y/Y Growth Comment
Fresenius Medical Care Ag reported decline in Net Income in the fourth quarter 2023 by -18.1% to $ 820.35 millions, from the same quarter in 2022.
The contraction in the fourth quarter 2023 Fresenius Medical Care Ag's Net Income compares unfavorably to the Company's average Net Income decrease of -2.95%.

Looking into fourth quarter 2023 results within Healthcare Facilities industry 4 other companies have achieved higher Net Income growth. While Fresenius Medical Care Ag' s Net Income fall of -18.1% ranks overall at the positon no. 406 in the fourth quarter 2023.




FMS Net Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -18.1 % -26.64 % -15.1 % -0.19 %
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   -18.1 % -26.64 % -15.1 % -0.19 %

Financial Statements
Fresenius Medical Care Ag's fourth quarter 2023 Net Income $ 820.35 millions FMS's Income Statement
Fresenius Medical Care Ag's fourth quarter 2022 Net Income $ 1,001.64 millions Quarterly FMS's Income Statement
New: More FMS's historic Net Income Growth >>


FMS Net Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   -18.1 % -26.64 % -15.1 % -0.19 %




Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #33
Overall #406

Net Income Y/Y Growth Statistics
High Average Low
43.17 % -2.95 % -27.61 %
(Dec 31 2018)   (Dec 31 2019)
Net Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #5
Healthcare Sector #33
Overall #406
Net Income Y/Y Growth Statistics
High Average Low
43.17 % -2.95 % -27.61 %
(Dec 31 2018)   (Dec 31 2019)

Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Fresenius Medical Care Ag's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FMS's IV. Quarter Q/Q Net Income Comment


Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FMS's IV. Quarter Q/Q Net Income Comment


Fresenius Medical Care Ag's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
(Dec 31 2021)
12 Months Ending
0
Cumulative Net Income 12 Months Ending $ 820.35 $ 1,001.64 $ 0.00 $ 1,365.31 $ 0.00
Y / Y Net Income Growth (TTM) -18.1 % -26.64 % - -15.1 % -
Year on Year Net Income Growth Overall Ranking # 406 # 0 # 0 # 1239 # 0
Seqeuential Net Income Change (TTM) -18.1 % -26.64 % - -15.1 % -
Seq. Net Income Growth (TTM) Overall Ranking # 406 # 0 # 0 # 1765 # 0




Cumulative Net Income growth Comment
Fresenius Medical Care Ag showed decline, but improvement compare to trailing twelve month Net Income decrease in Dec 31 2022. If the fiscal year would end in Dec 31 2023, Fresenius Medical Care Ag's annual Net Income fall would be -18.1% year on year to $820 millions.

Within the Healthcare sector 32 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 406.

Net Income TTM Q/Q Growth Statistics
High Average Low
43.17 %
-2.95 %
-27.61 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 33
Overall # 406

Net Income TTM Y/Y Growth Statistics
High Average Low
43.17 %
-2.95 %
-27.61 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 33
S&P 500 # 406
Cumulative Net Income growth Comment
Fresenius Medical Care Ag showed decline, but improvement compare to trailing twelve month Net Income decrease in Dec 31 2022. If the fiscal year would end in Dec 31 2023, Fresenius Medical Care Ag's annual Net Income drop would be -18.1% year on year to $820 millions.

Within the Healthcare sector 32 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 0 to 406.

Net Income TTM Q/Q Growth Statistics
High Average Low
43.17 %
-2.95 %
-27.61 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 5
Healthcare Sector # 33
Overall # 406

Net Income TTM Y/Y Growth Statistics
High Average Low
43.17 %
-2.95 %
-27.61 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 5
Sector # 33
S&P 500 # 406




Other Net Income Growth
Healthcare Facilities Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
FMS's Net Income Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for FMS's Competitors
Net Income Growth for Fresenius Medical Care Ag's Suppliers
Net Income Growth for FMS's Customers

You may also want to know
FMS's Annual Growth Rates FMS's Profitability Ratios FMS's Asset Turnover Ratio FMS's Dividend Growth
FMS's Roe FMS's Valuation Ratios FMS's Financial Strength Ratios FMS's Dividend Payout Ratio
FMS's Roa FMS's Inventory Turnover Ratio FMS's Growth Rates FMS's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Income for the quarter ending Dec 31 2023
Charles River Laboratories International inc -0.08%$ -0.081 millions
Regeneron Pharmaceuticals Inc -3.13%$ -3.133 millions
Haemonetics Corporation-5.17%$ -5.169 millions
Resmed Inc -7.16%$ -7.165 millions
Edwards Lifesciences Corporation-7.20%$ -7.204 millions
Bristol myers Squibb Company-12.99%$ -12.988 millions
Gilead Sciences Inc -13.23%$ -13.227 millions
Alpha Tau Medical Ltd -13.64%$ -13.640 millions
Masimo Corp-17.13%$ -17.125 millions
Merit Medical Systems Inc-17.28%$ -17.281 millions
Fresenius Medical Care Ag-18.10%$ -18.099 millions
Qiagen N v -19.35%$ -19.354 millions
Mettler toledo International Inc -30.49%$ -30.485 millions
Avantor Inc -30.49%$ -30.487 millions
Sanofi-35.93%$ -35.926 millions
Icu Medical Inc-38.15%$ -38.151 millions
Amedisys Inc -39.71%$ -39.707 millions
Avanos Medical Inc -40.34%$ -40.341 millions
Embecta Corp -42.90%$ -42.898 millions
Pro dex Inc -43.12%$ -43.117 millions
Becton Dickinson And Company-44.79%$ -44.794 millions
Bio techne Corp-45.08%$ -45.075 millions
Harmony Biosciences Holdings inc -45.15%$ -45.150 millions
Exagen Inc -45.72%$ -45.721 millions
Amgen Inc -52.54%$ -52.537 millions
Biogen Inc -54.70%$ -54.704 millions
Taro Pharmaceutical Industries Ltd-56.33%$ -56.330 millions
Bio rad Laboratories Inc -58.04%$ -58.043 millions
Teleflex Incorporated-60.42%$ -60.421 millions
Integra Lifesciences Holdings Corp-62.54%$ -62.539 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com